YSPSL (rPSGL‐Ig) for improvement of early renal allograft function: a double‐blind, placebo‐controlled, multi‐center Phase IIa study 1,2,3
暂无分享,去创建一个
G. Klintmalm | S. Hemmerich | S. Mulgaonkar | W. Irish | J. Kupiec-Weglinski | S. Jensik | E. Squiers | R. Alloway | A. Wiseman | L. Gaber | G. Lipshutz | B. Kahan | E. Katz | A. Osama Gaber | E. Steve Woodle | I. Bajjoka | P. Patton